Product Name | Phenylbutyrate Na |
Description |
HDAC inhibitor |
Purity | >98% |
CAS No. | 1716-12-7 |
Molecular Formula | C10H11NaO2 |
Molecular Weight | 186.18 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inducer |
Solubility | Soluble to 1100 mM in water and 100 mM in DMSO |
Source | Synthetic |
Appearance | White solid |
SMILES | C1=CC=C(C=C1)CCCC(=O)[O-].[Na+] |
InChI | InChI=1S/C10H12O2.Na/c11-10(12)8-4-7-9-5-2-1-3-6-9;/h1-3,5-6H,4,7-8H2,(H,11,12);/q;+1/p-1 |
InChIKey | VPZRWNZGLKXFOE-UHFFFAOYSA-M |
Safety Phrases |
Classification: Harmful. May be harmful if inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection |
Cite This Product | Phenylbutyrate Na (StressMarq Biosciences, Canada, Cat # SIH-255) |
Alternative Names | Sodium 4-phenylbutanoate, 4-PB |
Research Areas | Apoptosis, Cancer, Cancer Growth Inhibitors, HDAC Inhibitors |
PubChem ID | 5258 |
Scientific Background | Sodium phenylbutyrate is a small molecule with multiple mechanisms of action, including histone deacetylase inhibition, glutamine scavenging, and modulation of protein folding. In neuroscience, it has been shown to reduce tau pathology in Alzheimer's disease models, inhibit glioma cell proliferation, and enhance neuroprotective gene expression. Its ability to cross the blood-brain barrier and modulate epigenetic and metabolic pathways makes it a promising candidate for treating neurodegenerative and neurodevelopmental disorders. |
References |
1. Batashaw M.L., MacArthur R.B., and Tuchman M. (2001) J Pediatr. 138: S46-54. 2. Melichar B., et al. (1998) Clin Cancer Res. 4:3069-3076. |
Reviews
There are no reviews yet.